Department of Gastroenterological Surgery, Kansai Rosai Hospital, Amagasaki, Japan
Department of Gastroenterological Surgery, Osaka Police Hospital, Osaka, Japan.
In Vivo. 2019 Sep-Oct;33(5):1605-1608. doi: 10.21873/invivo.11643.
BACKGROUND/AIM: If both distant metastases and the primary tumour of colorectal cancer (CRC) are resectable, resection of the distant metastases is considered. The aim of this retrospective study was to determine the efficacy of curative resection of both primary and metastatic lesions in organs other than liver or lung in CRC patients.
The medical records of 23 CRC patients who received R0 resection for primary and metastatic regions between 2009 and 2018 were retrospectively analyzed.
The 3-year overall survival (OS) in all 23 cases was 80.0%. There was no clinicopathological factor associated with OS on univariate analysis.
Curative surgical resection appears to be useful for distant CRC metastases to organs other than liver or lung.
背景/目的:如果结直肠癌(CRC)的远处转移和原发性肿瘤均可切除,则考虑切除远处转移灶。本回顾性研究的目的是确定在CRC 患者中对肝脏或肺以外的其他器官的原发和转移病变进行治愈性切除的疗效。
回顾性分析了 2009 年至 2018 年间 23 例接受原发性和转移性区域 R0 切除的 CRC 患者的病历。
所有 23 例患者的 3 年总生存率(OS)为 80.0%。单因素分析显示,无与 OS 相关的临床病理因素。
治愈性手术切除似乎对肝脏或肺以外的其他器官的 CRC 远处转移有效。